Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells (Q38934121)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells |
scientific article |
Statements
1 reference
Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells (English)
1 reference
Hiromi Sato
1 reference
Sana Siddig
1 reference
Miaki Uzu
1 reference
Sayumi Suzuki
1 reference
Yuki Nomura
1 reference
Tatsuro Kashiba
1 reference
Keisuke Gushimiyagi
1 reference
Yuko Sekine
1 reference
Tomoya Uehara
1 reference
Yasushi Arano
1 reference
Katsunori Yamaura
1 reference
Koichi Ueno
1 reference
29 November 2014
1 reference
1 reference
746
1 reference
258-266
1 reference
Identifiers
1 reference
1 reference